- Fee assured
- Awaiting verification
I am a Consultant Medical Oncologist at York Teaching Hospital NHS Foundation Trust and Harrogate and District Hospital NHS Foundation Trust. I have been in post since 2010. I am the clinical lead for chemotherapy services. I am also Clinical Lecturer at the Hull & York Medical School.
I was born in the UK and grew up here. After completing my training at St. Bartholomew’s Hospital Medical College & The Royal London, I worked in hospitals in Kent, Essex and London. I completed my training in Medical Oncology in London and the South East including The Royal Marsden Hospital, Guys and St Thomas’ and The Kent Oncology Centre.
My BSc was in Human Genetics at UCL and I spent 3 years at The University of Kent lecturing and carrying out cancer research in the field of growth factor receptors. Currently, I am research active and involved with collaborative clinical trials at York and Harrogate Hospitals.
My spare time is spent with my family and in climbing and swimming to keep fit; I also enjoy reading and guitar.
I specialise in the management and treatment of Lung Cancer and Bowel Cancer. I also have an interest in the treatment of Neuroendocrine Cancers and Cancer of Unknown Origin.
I believe passionately in providing personalised and holistic cancer care, putting every patient's individual wishes and dignity at the centre of my management. Excellent communication with patients and their loved ones, professionalism, kindness, respect and compassion is at the heart of everything I do.
Areas of interest
Cancer of Unknown Origin
Current NHS consultant posts held
Consultant Medical Oncologist at York Teaching Hospital NHS Foundation Trust
Consultant Medical Oncologist at Harrogate and District Hospital NHS Foundation Trust
EGFR Tumour Biology and Therapeutics
2009: “Top 10 Cited” award for published paper in European Journal Of Cancer
2007: Prize for best research poster presentation: EGFR Cancer Therapeutics, at Annual Research Meeting, MTW Trust 2007
1996: Distinction Award in Medicine and Surgery
2018: Colorectal Cancer Presenting as Single Pulmonary Hilar Lymph Node Metastasis; Ahmed M. Habib,1,2 Xenophon Kassianides,1 Samuel Chan,3 Mahmoud Loubani,1 and Syed Qadri1. Case Reports in Surgery
Volume 2018 (2018), Article ID 5474919
2017: Safety Aspects of Immunotherapy. Poster Presentation at York Teaching Hospital NHS Foundation Trust Patient Safety Conference.
2015: Safety Mechanisms for a Clinical Chemotherapy Service. Poster Presentation at York Teaching Hospital NHS Foundation Trust Inaugural Patient Safety Conference. 22nd May 2015, York
2014: Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme. Khan F, Ottensmeier C, Popat S, Dua D, Dorey N, Ellis S, Upadhyay S, Califano R, Chan S, Lee L, Ali CW, Nicolson M, Bates AT. Eur J Cancer. 2014 Jul;50(10):1717-21. doi: 10.1016/j.ejca.2014.03.001. Epub 2014 Apr 10
2012: A monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell lines. Blackburn E, Zona S, Murphy ML, Brown IR, Chan SK, Gullick WJ. Breast Cancer Res Treat. 2012 Jul;134(1):53-9. doi: 10.1007/s10549-011-1908-1. Epub 2011 Dec 15
For a more comprehensive list of publications; please contact me directly.
Courses offered to GPs
My last free seminar was in July 2017; I talked to a local GP group regarding Cancer Immunotherapy.
Please feel free to contact me for any further meetings - I would be happy to arrange.
- MBBS St Bartholomew's Hospital, London University 1998
- BSc Human Genetics University College London 1995
- MRCP MRCP (UK) 2001
- Medical Oncology CCT London and KSS Deanery (UK) 2010
Reference number 4547451
Professional bodies (positions held - last 3 yrs)
- Member RCP Royal College of Physicians (UK) 2018
- Member ACP Association Cancer Physicians 2018
- Member MPS Medical Protection Society 2018
- Clinical Lecturer in Medicine Hull and York Medical School 2018
- Consultant Advisor Roy Castle Lung Cancer Foundation 2018
- Lead for Clinical Chemotherapy Services, York York Teaching Hospital NHS Foundation Trust 2018
- Member of Yorkshire Clinical Chemotherapy Services Group Yorkshire Cancer Network Group 2018
Details of entry to specialist register
- Medical Oncology, Oncology; GMC registered, 2010
Affiliations / memberships
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Emergency Helpline number for Healthcare At Home Team (if on Chemotherapy): number supplied by Healthcare at Home Team on an individual basis.
Emergency Contact No.for Dr S Chan:
0753 4030 835